Zhitong Finance App News, Zhongsheng Beikong Biotechnology (08247.HK) announced that from June 15 to July 14, 2026, Mr. Chen Peng, the chairman, president, executive director and major shareholder of the company purchased approximately 43.02 million shares of the company's domestic shares through Jingning Guoke Kangyi Enterprise Management Center (limited partnership) and Guoke Health Institute Innovation Research Institute (Hefei) partnership (limited partnership) at a total cost of about RMB 10.53 million (the purchase price is RMB 2.40 to RMB 2.50 per share). Take up the company's issued shares 2.97% of the total.

Zhitong Finance App News, Zhongsheng Beikong Biotechnology (08247.HK) announced that from June 15 to July 14, 2026, Mr. Chen Peng, the chairman, president, executive director and major shareholder of the company purchased approximately 43.02 million shares of the company's domestic shares through Jingning Guoke Kangyi Enterprise Management Center (limited partnership) and Guoke Health Institute Innovation Research Institute (Hefei) partnership (limited partnership) at a total cost of about RMB 10.53 million (the purchase price is RMB 2.40 to RMB 2.50 per share). Take up the company's issued shares 2.97% of the total.